-
CDK9: A key player in cancer and other diseases
Lia Carolina Franco, Fátima Morales, Silvia Boffo, and Antonio Giordano
Journal of Cellular Biochemistry
(2017)
:
-
Targeting of CDK9 with indirubin 3’-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice
Sandra Medina-Moreno, Thomas C. Dowling, Juan C. Zapata, Nhut M. Le, Edward Sausville, Joseph Bryant, Robert R. Redfield,
Alonso Heredia, and Fatah Kashanchi
PLOS ONE
(2017)
12 :e0183425
-
CDK5 in oncology: recent advances and future prospects
Jimma Likisa Lenjisa, Solomon Tadesse, Nishat Zareen Khair, Malika Kumarasiri, Mingfeng Yu, Hugo Albrecht, Robert Milne, and
Shudong Wang
Future Medicinal Chemistry
(2017)
:
-
Novel twists in hormone-mediated carcinogenesis
Wayne D Tilley
Endocrine-Related Cancer
(2016)
23 :E9
-
miR-206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9
Chi Pang, Gang Huang, Kaili Luo, Yuying Dong, Fengtian He, Guankui Du, Man Xiao, and Wangwei Cai
Cancer Medicine
(2017)
6 :2398
-
The emerging picture of CDK9/P-TEFb: more than 20 years of advances since PITALRE
Nikolas Ferreira dos Santos Paparidis, Maxwell Castro Durvale, and Fernanda Canduri
Mol. BioSyst.
(2017)
13 :246